A Repeat Ascending Dosing Study of the Safety and Clinical Activity of R-3750 in Patients With Mild to Moderate COPD

NCT07076290 · clinicaltrials.gov ↗

PHASE1

Phase

NOT_YET_RECRUITING

Status

27

Enrollment

INDUSTRY

Sponsor class

Conditions

COPD (Chronic Obstructive Pulmonary Disease)
COPD Exacerbation
COPD Exacerbation Acute

Interventions

DRUG: R-3750

Sponsor

Rise Therapeutics LLC